Lowering prostate radiation dose for MRI-visible tumors
Part of Cancer clinical trials.
This trial tests whether men with certain prostate cancer seen on MRI can safely receive a lower dose of radiation. The goal is to keep cancer control while possibly reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older
- Your prostate cancer has been confirmed on biopsy and is “low to intermediate grade” (Gleason 3+3, 3+4, or 4+3)
- Your MRI shows the tumor is limited to T2 (or less) and is clearly seen, with MRI findings called PIRADS v2 grade 3 or higher
- Your PSA is under 20 before starting any hormone treatment (ADT)
- You can have hormone treatment only if it’s normally used for your situation, and your daily health status is good (WHO 0–2)
- You can safely have MRI scans and answer questionnaires during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a lower dose of radiation can effectively treat prostate cancer while reducing side effects. It is for men with certain types of prostate cancer that are visible on an MRI.
This trial tests whether a shorter course of radiation works as well as the usual longer course for people with high-risk prostate cancer. The goal is to keep cancer control while possibly reducing treatment time and inconvenience.
This trial is comparing two different MRI-guided radiation treatment plans to see which one better improves sexual quality of life in prostate cancer. It may help people decide between shorter or more treatment-session radiation approaches.
This trial studies a more sped-up radiation schedule for men with certain local prostate cancers, given together with hormone therapy. It aims to keep cancer control while possibly reducing treatment time and making care easier.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This trial tests a shorter radiation plan using an MRI machine to guide treatment. The goal is to see if two high-dose sessions work just as well as longer treatment, with fewer side effects. It is for men with low or intermediate risk prostate cancer.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.